Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,445.00
Bid: 1,435.00
Ask: 1,437.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.139%)
Open: 1,485.00
High: 1,485.00
Low: 1,410.00
Prev. Close: 1,445.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Galliford Rises As Dividend Set To Return

Fri, 13th Nov 2020 11:13

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.

----------

FTSE 100 - WINNERS

----------

Whitbread, up 1.8%. Barclays upgraded Whitbread to Overweight from Equal Weight, deeming the Premier Inn hotel chain owner one of the most attractive stocks in the hospitality sector following this week's positive coronavirus vaccine news.

----------

FTSE 250 - WINNERS

----------

Royal Mail, up 4.0%. Credit Suisse upgraded the postal operator to Neutral from Underperform.

----------

FTSE 250 - LOSERS

----------

Indivior, down 2.5%. The drugmaker said a US federal court in the Western District of Virginia has approved the agreement between the pharmaceuticals firm and the US Department of Justice over resolving criminal charges in the US related to its Suboxone film opioid dependence medication. In mid-July, Indivior agreed to part with USD600 million to resolve the charges with the US Justice Department. In April 2019 a grand jury in the Western District of Virginia had issued an indictment of 28 felony counts against the company related to fraud. In a statement Friday, Indivior noted the federal court has dismissed all of these charges. Indivior could have faced USD3 billion in fines related to the matters. "As previously noted, Indivior is pleased to put this matter behind it and move forward in a manner that provides certainty to its business," the firm said. The stock is three times higher since the start of 2020.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Galliford Try Holdings, up 23%. The construction company said productivity has been at "near-normal levels" since the start of its financial year on July 1, with the construction firm saying it will continue to operate "normally during the second national lockdown" in England. Galliford said it is performing in line with its expectations, with an "excellent" first half-year average month-end cash position towards the upper end of previous guidance of GBP125 million to GBP145 million. "The board expects the group to return to profitability in the first half of this financial year and a resumption of dividend with the interim results," Galliford said. In financial 2020, no final dividend was declared, following Galliford's decision to cancel the interim dividend in March. The full year dividend for financial 2019 was 58.0 pence.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Nakama Group, down 29%. The recruitment consultancy said its recent trading has been in line with management expectations but remains "difficult", and it is concerned about cashflow. Nakama previously had guided for revenue in the year ending March 31 to drop 28% year on year to GBP9.7 million from GBP13.4 million. "The Covid-19 pandemic had an immediate and significant impact on the group's trading activities. The company has utilised a number of government initiatives in the UK, Hong Kong and Singapore in order to preserve cash and retain the businesses ability to continue to trade," Nakama said. Rising virus infections has led to a second national lockdown in the UK, which Nakama said means its "market conditions remain difficult".

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
30 Jun 2021 17:05

LONDON MARKET CLOSE: Lower finish fails to dent FTSE's strong quarter

LONDON MARKET CLOSE: Lower finish fails to dent FTSE's strong quarter

Read more
30 Jun 2021 13:44

Wednesday broker round-up

(Sharecast News) - Workspace: RBC Capital Markets upgrades to outperform with a target price of 1,050p.

Read more
30 Jun 2021 12:17

LONDON MARKET MIDDAY: Stocks slide ahead of US ADP jobs report

LONDON MARKET MIDDAY: Stocks slide ahead of US ADP jobs report

Read more
30 Jun 2021 10:41

Indivior raises profit and revenue guidance after strong start to year

Indivior raises profit and revenue guidance after strong start to year

Read more
30 Jun 2021 09:02

LONDON MARKET OPEN: Indivior shines after upgrading guidance

LONDON MARKET OPEN: Indivior shines after upgrading guidance

Read more
30 Jun 2021 07:58

LONDON MARKET PRE-OPEN: Dividend contrast from Dixons and Stagecoach

LONDON MARKET PRE-OPEN: Dividend contrast from Dixons and Stagecoach

Read more
30 Jun 2021 07:35

Indivior lifts 2021 guidance after better-than-expected H1

(Sharecast News) - Opioid addiction treatment maker Indivior lifted its 2021 guidance on Wednesday following a better-than-expected business performance through the first half of the year.

Read more
21 Jun 2021 09:34

BROKER RATINGS: UBS cuts Rio Tinto to Sell; Morgan Stanley ups Ocado

BROKER RATINGS: UBS cuts Rio Tinto to Sell; Morgan Stanley ups Ocado

Read more
8 Jun 2021 14:27

IN BRIEF: Indivior secures license for cannabis disorder treatment

IN BRIEF: Indivior secures license for cannabis disorder treatment

Read more
8 Jun 2021 12:36

Indivior joins forces with France's Aelis on treatment for cannabis use disorder

(Sharecast News) - Indivior said on Tuesday that it has teamed up with French biotechnology group Aelis to advance the clinical development of a treatment for cannabis use disorder.

Read more
8 Jun 2021 12:36

Indivior teams up with Aelis on treatment for cannabis use disorder

(Sharecast News) - Indivior said on Tuesday that it has teamed up with French biotechnology group Aelis to advance the clinical development of a treatment for cannabis use disorder.

Read more
6 May 2021 17:50

UPDATE: Pay comes under spotlight at BAE, Indivior and Rio Tinto AGMs

UPDATE: Pay comes under spotlight at BAE, Indivior and Rio Tinto AGMs

Read more
29 Apr 2021 16:11

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
29 Apr 2021 12:26

Indivior maintains 2021 guidance as first quarter revenue increases

Indivior maintains 2021 guidance as first quarter revenue increases

Read more
28 Apr 2021 10:47

Indivior says US filings "administrative", no new Suboxone settlements

Indivior says US filings "administrative", no new Suboxone settlements

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.